"The Report Partnerships,
Licensing, Investments and M&A Deals and Trends for September
2016 in Pharmaceuticals provides information on pricing, market
analysis, shares, forecast, and company profiles for key industry
participants. - MarketResearchReports.biz"
GlobalData's
Partnerships, Licensing, Investments and M&A Deals and Trends for
September 2016 in Pharmaceuticals report is an essential source of
data and trend analysis on partnerships, licensing, mergers and
acquisitions (M&As) and financings in the pharmaceuticals
industry. The report provides detailed information on partnership and
licensing transactions, M&As, equity/debt offerings, private
equity, and venture financing registered in the pharmaceuticals
industry in September 2016. The report portrays detailed comparative
data on the number of deals and their value in the last six months,
subdivided by deal types, various therapy areas, and geographies.
Additionally, the report provides information on the top financial
advisory firms in the pharmaceuticals industry.
Data
presented in this report is derived from GlobalDatas proprietary
in-house Pharmaceuticals eTrack deals database and primary and
secondary research.
View Full Report at :
http://www.marketresearchreports.biz/analysis/879237
Scope
-
Analysis of the market trends for the pharmaceutical industry in the
global arena.
-
Review of deal trends in the cardiovascular, central nervous system,
dermatology, ear nose throat disorders, gastrointestinal, genito
urinary system and sex hormones, hematological disorders, hormonal
disorders, immunology, infectious disease, male health, metabolic
disorders, mouth and dental disorders, musculoskeletal, oncology,
ophthalmology, respiratory, toxicology, and women's health segments.
-
Analysis of partnerships, licensing, M&As, equity/debt offerings,
private equity, and venture financing deals in the pharmaceutical
industry.
-
Analysis of therapy areas which are very active in terms of venture
capital financing, partnerships, licensing agreements, equity/debt
offerings, and M&As.
-
Analysis of deals based on different payment modes, including upfront
and milestone payments, primarily in partnerships and licensing
agreements in the pharmaceutical industry.
-
Analysis of partnership and licensing deals based on clinical stage
of development of products.
-
Summary of the pharmaceutical deals globally in the six months.
-
Information on the top deals happened in the pharmaceutical industry.
-
Geographies covered include - North America, Europe, Asia Pacific,
South & Central America, and the Middle East & Africa.
-
League tables of financial advisors in M&As and equity/debt
offerings. This includes key advisors such as Morgan Stanley, Credit
Suisse, and Goldman Sachs.
Get Sample Copy Of This Report
@ http://www.marketresearchreports.biz/sample/sample/879237
Reasons to buy
- Enhance your decision making
capability in a more rapid and time sensitive manner.
- Find out the major deal
performing segments for investments in your industry.
- Evaluate the types of companies
which are entering into partnership or licensing agreements;
divesting and acquiring assets.
- Identify companies that are
aggressively looking to raise capital in the market
- Evaluate niche therapy areas
that are receiving majority of the upfront and milestone payments in
the pharmaceutical industry.
- Identify the key venture
capitalists, who are financing the pharmaceutical and biotech
companies.
- Evaluate the clinical
development stages where majority of the partnerships and licensing
agreements are happening.
- Do deals with an understanding
of how competitors are financed, and the mergers and partnerships
that have shaped the pharmaceutical industry.
- Identify growth segments and
opportunities in each region within the industry.
- Look for key financial advisors
where you are planning to raise capital from the market or for
acquisitions within the industry.
Table Of Content
1
Table of Contents 2
1.1
List of Tables 5
1.2
List of Figures 9
2
Pharmaceuticals & Healthcare, Global, Deal Summary, 12
2.1
Pharmaceuticals & Healthcare, Global, Deal Analysis, September
2016 12
2.2
Pharmaceuticals & Healthcare, Global, Major Deals, September 2016
14
2.2.1
Shire Raises USD12.1 Billion in Public Offering of Notes 14
2.2.2
Gilead Sciences Raises USD5 Billion in Public Offering of Notes 15
2.2.3
Johnson & Johnson to Acquire Abbott Medical Optics from Abbott
Laboratories for USD4.32 Billion 15
2.2.4
Sanofi Prices Public Offering of Notes for USD3.3 Billion 16
2.2.5
Allergan to Acquire Tobira Therapeutics in Tender Offer 16
2.3
Pharmaceuticals & Healthcare, Global, by Type, Number of Deals,
September 2016 19
2.4
Pharmaceuticals & Healthcare, Global, by Type, Deal Values,
September 2016 20
3
Pharmaceuticals and Healthcare, Global, Deals, Summary, by Type 21
3.1
Pharmaceuticals & Healthcare, Global, M&A, September 2016 21
3.1.1
Top M&A Deals in September 2016 22
3.1.2
Pharmaceuticals & Healthcare, Global, M&A Deals by Therapy
Area, April 2016 - September 2016 23
3.2
Pharmaceuticals & Healthcare, Global, Equity Offering Deals,
September 2016 25
3.2.1
Top Equity Offering Deals in September 2016 26
3.2.2
Pharmaceuticals & Healthcare, Global, Equity Offering Deals by
Therapy Area, April 2016 - September 2016 27
3.3
Pharmaceuticals & Healthcare, Global, Private Equity and Venture
Capital Deals, September 2016 28
3.3.1
Top PE/VC Deals in September 2016 29
3.3.2
Pharmaceuticals & Healthcare, Global, PE/VC by Therapy Area,
September 2016 30
3.3.3
Pharmaceuticals & Healthcare, Global, Venture Capital Deals by
Stage of Financing, September 2016 31
3.3.4
Pharmaceuticals & Healthcare, Global, Top Venture Financing
Firms, April 2016-September 2016 33
3.3.5
Pharmaceuticals & Healthcare, Global, Top VC Backed Companies,
April 2016-September 2016 34
3.4
Pharmaceuticals & Healthcare, Global, Partnership Deals,
September 2016 35
3.5
Pharmaceuticals & Healthcare, Global, Partnership Deals by
Therapy Area, April 2016 - September 2016 37
3.6
Pharmaceuticals & Healthcare, Global, Partnership Deals by
Upfront and Milestone Payments and Deal Values (US$ m), September
2016 39
3.6.1
Pharmaceuticals & Healthcare, Global, Top Partnership Deals by
Payment Mode, September 2016 40
3.7
Pharmaceuticals & Healthcare, Global, Partnership Deals by
Therapy Area, by Upfront and Milestone Payments and Deal Values (US$
m), April 2016 - September 2016 41
3.8
Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase,
Number Of Deals, April 2016 - September 2016 43
3.9
Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase,
Deal Values (US$ m), April 2016 - September 2016 44
3.10
Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase,
by Upfront & Milestone Payments and Deal Values (US$ m), April
2016 - September 2016 46
4
Pharmaceuticals & Healthcare, Global, Licensing Agreements,
September 2016 48
4.1
Pharmaceuticals & Healthcare, Global, Licensing Agreements,
September 2016 48
4.2
Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals,
Upfront and Milestone Payments and Deal Values (US$ m), September
2016 50
4.3
Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals
by Therapy Area, Total Deal Values (US$ m), April 2016 - September
2016 52
4.4
Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals
by Therapy Area, Upfront Payments and Milestone Payments (US$ m),
April 2016 - September 2016 54
4.5
Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals
by Phase, Total Deal Values (US$ m), April 2016 - September 2016 56
About us
MarketResearchReports.biz
is the most comprehensive collection of market research
reports.MarketResearchReports.Biz services are specially designed to
save time and money for our clients.We are a one stop solution for
all your research needs, our main offerings are syndicated research
reports, custom research, subscription access and consulting
services. We serve all sizes and types of companies spanning across
various industries.
Contact
Mr.
Nachiket
90
Sate Street, Suite 700
Albany,
NY 12207
Tel:
+1-518-621-2074
No comments:
Post a Comment